|
 |
DesonideThis page contains recent news articles, when available, and an overview of Desonide but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Desonide (when available) Budesonide is a synthetic corticosteroid indicated for the treatment of mild to moderate active Crohn's disease involving the ileum and/or the ascending colon. Budesonide is used in Crohn's disease to decrease the symptoms and inflammation associated with the disease, especially at times of flare up. Budesonide has a high topical glucocorticosteroid (GCS) activity and a substantial first pass elimination. The formulation contains granules which are coated to protect dissolution in gastric juice, but which dissolve at pH >5.5, ie, normally when the granules reach the duodenum. Thereafter, a matrix of ethylcellulose with budesonide controls the release of the drug into the intestinal lumen in a time-dependent manner. For the treatment of mild to moderate active Crohn's disease. Mechanism Of Action: The exact mechanism of action of budesonide in the treatment of Crohn's disease is not fully understood. However, being a glucocorticosteroid, budesonide has a high local anti-inflammatory effect. News Articles on Budesonide … ) Announces FDA Approval of Desonate(TM) (Desonide) Gel 0.05% With ... - Oct 23, 2006 Desonide is the leading low potency corticosteroid in the US dermatology market ... Desonate is the first product to contain 0.05 percent desonide in an ... Free with registration - PR Newswire - AccessMyLibrary.com Safety and efficacy of desonide hydrogel 0.05% in pediatric subjects... - Feb 1, 2007 Low to mid potency corticosteroids remain a cornerstone of therapy for atopic dermatitis (AD). Since AD is most prevalent in the younger pediatric ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com Learn about Desonide Topical from Consumer Reports Health. - Jan 7, 2005 Desonide is used to treat the redness, swelling, itching, and discomfort of various skin conditions. Desonide is in a class of medications called topical ... consumerreports.org Taking Desonide Topical from Consumer Reports Health. - Jan 7, 2005 Desonide may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:. Some side effects can be serious. ... consumerreports.org … Commercial Launch of Desonate(TM) (desonide) Gel 0.05% With … - Feb 12, 2007 Formulated with desonide, the leading low-potency corticosteroid used in dermatology ... SkinMedica's Desonate(TM) (desonide) Gel 0.05% is indicated for the ... Free with registration - PR Newswire - AccessMyLibrary.com … announced the availability of the Desonate (desonide) Gel (0.05%... - Feb 1, 2008 SkinMedica announced the availability of the Desonate (desonide) Gel (0.05% 120 g twin pack) for the treatment of mild to moderate atopic dermatitis. ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com Connetics Launches Verdeso Foam for the Treatment of Mild-to-Moderate... - Nov 8, 2006 Approximately 7.7 million prescriptions are written annually in the US by dermatologists for low-potency steroid products, and desonide is the leading ... RedOrbit Verdeso (desonide) Foam, 0.05%, has been FDA-approved for the … - Jan 8, 2007 Verdeso (desonide) Foam, 0.05%, has been FDA-approved for the treatment of mild to moderate atopic dermatitis (eczema) in adults and children as young as ... Free with registration - Drug Topics - AccessMyLibrary.com … : SkinMedica Introduces Desonate(R) (desonide) Gel 0.05% TwinPack... - Jan 8, 2008 SkinMedica Introduces Desonate(R) (desonide) Gel 0.05% TwinPack for Treatment of Mild to Moderate Atopic Dermatitis. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research … Commercial Launch of Desonate(TM) (desonide) Gel 0.05% With … - Feb 12, 2007 SkinMedica(R) Announces Commercial Launch of Desonate(TM) (desonide) Gel 0.05% With Patented Hydrogel Technology for Treatment of Mild-to-Moderate Atopic ... Pay-Per-View - PR Newswire - HighBeam Research … announced the availability of the Desonate (desonide) Gel (0.05%... - Feb 1, 2008 SkinMedica announced the availability of the Desonate (desonide) Gel (0.05% 120 g twin pack) for the treatment of mild to moderate atopic dermatitis. Pay-Per-View - Medical Marketing & Media - HighBeam Research Illinois Administrative Code - 77 Ill. Adm. Code 790.2932 DESONIDE ( … - Aug 10, 2005 77 Ill. Adm. Code 790.2932 DESONIDE (Repealed) Repealed. (Source: Repealed at 17 Ill. Reg. 15916, effective September 20, 1993) ... Pay-Per-View - Illinois Administrative Code - Loislaw Positive Ph III data for Connetics' Desilux.(desonide)(Brief Article) - Aug 22, 2005 Connetics Corp, a USA-based specialty pharmaceutical company focused on developing and commercializing dermatology products, has unveiled positive data from ... $4.95 - Pharma Marketletter - ECNext Corrections.(Correction notice) - Feb 1, 2008 ...for Atopic Dermatitis," January 2007, p. 3), the steroid desonide should have been described as being available in a proprietary hydrogel formulation. Free with registration - Pediatric News - AccessMyLibrary.com Verdeso (desonide) Foam, 0.05%, has been FDA-approved for the … - Jan 8, 2007 Verdeso (desonide) Foam, 0.05%, has been FDA-approved for the treatment of mild to moderate atopic dermatitis (eczema) in adults and children as young as ... $9.94 - Drug Topics - Alacra Store Verdeso (desonide) Foam, 0.05%, has been FDA-approved for the … - Jan 8, 2007 Verdeso (desonide) Foam, 0.05%, has been FDA-approved for the treatment of mild to moderate atopic dermatitis (eczema) in adults and children as young as ... $4.95 - Drug Topics - ECNext Press Release: Galderma and SkinMedica to Co-Promote Desonate(TM); … - Nov 7, 2006 Desonate is a low potency topical steroid (.05 percent desonide) formulated ... The desonide molecule is a leading topical corticosteroid in the US market ... Pay-Per-View - PR Newswire - HighBeam Research SkinMedica and Galderma to Co-Promote Desonate(TM). - Nov 7, 2006 ..."Galderma's experience with the desonide molecule, their exceptional pediatric ... Desonide is the leading low potency corticosteroid in the US dermatology ... Free with registration - PR Newswire - AccessMyLibrary.com Press Release: SkinMedica(R) Presents Three Scientific Posters at the... - Feb 5, 2007 Desonate is a low-potency topical steroid (desonide) formulated ... ... Article: Safety and efficacy of desonide hydrogel 0.05% in pediatric ... ... Pay-Per-View - PR Newswire - HighBeam Research A novel hydrogel vehicle formulated for the treatment of atopic... - Jul 1, 2007 Recently, phase III clinical studies have demonstrated the safety and efficacy of a novel aqueous hydrogel vehicle for desonide delivery in mild to moderate ... $4.95 - Journal of Drugs in Dermatology - ECNext With topical steroids for AD, follow age-specific indications.(Clinica... - Aug 1, 2007 The desonide products received marketing approval just last fall for up to 4 ... Although the desonide gel labeling carties a warning about possible HPA ... Free with registration - Pediatric News - AccessMyLibrary.com FDA Approves Connetics' Verdeso Foam for the Treatment of Mild-to- … - Sep 19, 2006 The low-potency corticosteroid desonide in VersaFoam-EF has been shown in our clinical trials to be safe and effective in children as young as three months ... Free with registration - Business Wire - AccessMyLibrary.com SkinMedica(R) Announces New Debt Facility and FDA Acceptance of Its … - Jun 21, 2006 Approval of Desonate(TM) (desonide) would provide SkinMedica with its first steroid product in the $1.1 billion dollar topical steroid market. ... Genetic Engineering News - Genetic Engineering News (press release) Be age-specific with topical steroids for AD.(Dermatologic Therapy) - Jun 1, 2007 The desonide products received marketing approval just last fall for up to 4 ... Although the desonide gel labeling carries a warning about possible HPA ... $4.95 - Skin & Allergy News - ECNext New foam spares the sting in atopic dermatitis Tx.(Dermatologic... - Jun 1, 2006 Desonide 0.05% foam (Desilux) is an investigational agent that uses ... Adverse events occurred in 6% of the desonide-foam group and 15% of controls. ... Free with registration - Skin & Allergy News - AccessMyLibrary.com Alcohol-free foam good for atopic dermatitis. - May 1, 2006 Desonide 0.05% foam (Desilux) is an investigational agent that uses ... Adverse events occurred in 6% of the desonide-foam group and 15% of controls. ... Free with registration - Pediatric News - AccessMyLibrary.com Press Release: Study Shows New Atopic Dermatitis Therapy Significantly... - Mar 3, 2006 PR Newswire; February 5, 2007 ; 700+ words ... ... the benefits of Desonate(TM) (desonide) Gel 0.05 ... FDA for the treatment of atopic dermatitis in ... Pay-Per-View - PR Newswire - HighBeam Research SkinMedica(R) Presents Three Scientific Posters at the 65th Annual … - Feb 5, 2007 Desonate is a low-potency topical steroid (desonide) formulated in Dow's proprietary ... SkinMedica's Desonate(TM) (desonide) Gel 0.05% is indicated for the ... RedOrbit Connetics Corporation - Company Snapshot - AlacraStore.com - Oct 3, 2008 Verdeso (desonide) Foam, 0.05%, has been FDA-approved for the treatment of mild to moderate atopic dermatitis (eczema) in adults and children as young as ... Pay-Per-View - co - Alacra Store Connetics Reports Positive Results From Desilux Phase III Trial; NDA ... - Aug 15, 2005 Desonide is the leading topical steroid prescribed by dermatologists within the US in the 7.7 million annual prescription low-potency steroid market. ... $4.95 - Business Wire - ECNext SkinMedica, Inc. - Company Snapshot - AlacraStore.com - Aug 29, 2008 SkinMedica Introduces Desonate(R) (desonide) Gel 0.05% TwinPack for Treatment of Mild to ... Desonate (desonide) Gel #.##% is FDAapproved and available from ... Pay-Per-View - co - Alacra Store Connetics Presents Eight Scientific Posters at the 64th Annual... - Mar 2, 2006 A Phase 3 Double-Blind, Randomized, Vehicle-Controlled Study of Desonide Emulsion ... Connetics is developing Desilux(TM) (desonide) VersaFoam-EF, 0.05%, ... Free with registration - Business Wire - AccessMyLibrary.com Seborrheic dermatitis: an overview.(disease overview)(Disease/Disorder... - Jul 1, 2006 ...(2,20) A topical azole preparation may be combined with a desonide regimen (one ... A double-blind placebo-controlled study of ketoconazole + desonide gel ... Free with registration - American Family Physician - AccessMyLibrary.com Article: Verdeso foam, dermatop emollient cream.(New & Approved) - … - Nov 1, 2006 Verdeso foam, dermatop emollient cream.(New & Approved) ... find Pediatric News articles. Verdeso Foam (Verdeso [desonide] Foam 0.05%, Connetics Corp. Pay-Per-View - Pediatric News - HighBeam Research Competitors by Product Report - Dec 16, 2006 Products:. Primolux (Clobetasol Propionat); Verdeso Foam (Desonide) ... The Dow Chemical Company (DOW) Products:. Desonate (Desonide) ... $75.00 - Revere Reports - Revere Seborrheic Dermatitis Therapy; Positive phase III results reported... - Jan 21, 2005 Both studies had four treatment arms (Sebazole, vehicle, desonide, a topical steroid, and the combination of desonide with Sebazole). ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Seborrheic Dermatitis Therapy; Positive phase III results reported... - Jan 17, 2005 Both studies had four treatment arms (Sebazole, vehicle, desonide, a topical steroid, and the combination of desonide with Sebazole). ... Pay-Per-View - Pharma Business Week - Factiva, from Dow Jones Merger and Acquisition Scenario - Sep 6, 2008 Desonate (Desonide); Dowpharma Contract Manufacturing Services; The Dow Chemical Company Chemicals/Performance Chemicals; The Dow Chemical Company ... $250.00 - Revere Reports - Revere Seborrheic dermatitis: an overview.(disease overview)(Disease/Disorder... - Jul 1, 2006 ...(2,20) A topical azole preparation may be combined with a desonide regimen (one ... A double-blind placebo-controlled study of ketoconazole + desonide gel ... $4.95 - American Family Physician - ECNext Merger and Acquisition Scenario - May 3, 2008 Desonate (Desonide); Dowpharma Contract Manufacturing Services ... Desonate (Desonide). Outsourced Services. Development/Manufacturing Services ... $250.00 - Revere Reports - Revere Press Release: Research and Markets : Comprehensive analysis of the … - Jul 4, 2005 Indication: Mild to moderate atopic dermatitis in patients [greater than or equal to] 3 months of age. Pharmacology: Desonide, like other topical ... Pay-Per-View - M2 Presswire - HighBeam Research Press Release: Barrier Therapeutics to Present Data on Azoline and … - Feb 18, 2005 Poster Number: P1831 * The Irritation Potential of Topical Formulations Containing Ketoconazole 2% and Desonide 0.05% Alone and in Combination; ... Pay-Per-View - PR Newswire - HighBeam Research Competitors by Product Report - Apr 12, 2008 Betamethasone Dipropionate; Clobetasol Propionate Foam; Desonide; Desoximetasone; Fluticasone Propionate; Halobetasol Propionate; Hydrocortisone Acetate ... $75.00 - Revere Reports - Revere Barrier Therapeutics to Present Data on Azoline and Sebazole(TM) at... - Feb 18, 2005 Poster Number: P1831 * The Irritation Potential of Topical Formulations Containing Ketoconazole 2% and Desonide 0.05% Alone and in Combination; ... $4.95 - PR Newswire - ECNext Merger and Acquisition Scenario - Sep 6, 2008 Desonate (Desonide); Dowpharma Contract Manufacturing Services; The Dow Chemical Company Chemicals/Performance Chemicals; The Dow Chemical Company ... $250.00 - Revere Reports - Revere Press Release: SkinMedica and Galderma to Co-Promote Desonate(TM). … - Nov 7, 2006 Article: SkinMedica Introduces Desonate(R) (desonide) Gel 0.05% . ... SkinMedica announced the availability of the Desonate (desonide) Gel (0.05% 120 g twin ... Pay-Per-View - PR Newswire - HighBeam Research Seborrheic Dermatitis Therapy; Positive phase III results reported... - Jan 22, 2005 Both studies had four treatment arms (Sebazole, vehicle, desonide, a topical steroid, and the combination of desonide with Sebazole). ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Merger and Acquisition Scenario - Apr 19, 2008 Desonate (Desonide); Dowpharma Contract Manufacturing Services ... Desonate (Desonide). Outsourced Services. Development/Manufacturing Services ... $250.00 - Revere Reports - Revere Connetics Reports Highlights of 2005 Analyst and Investor Day;... - Apr 14, 2005 ...--Presenting Desilux(TM) VersaFoam-EF Program Data: Connetics presented positive results from its Desilux-EF (desonide 0.05%) Phase II trial for atopic ... $4.95 - Business Wire - ECNext Merger and Acquisition Scenario - Apr 7, 2007 Target. Desonate (Desonide); Dowpharma Contract Manufacturing Services ... Desonate (Desonide). Outsourced Services. Development/Manufacturing Services ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 6, 2008 Desonate (Desonide); Dowpharma Contract Manufacturing Services; The Dow Chemical Company Chemicals/Performance Chemicals; The Dow Chemical Company ... $250.00 - Revere Reports - Revere Stiefel Plans $640M Acquisition Of Dermatology Firm Connetics - Oct 24, 2006 Verdeso (desonide) foam, a low-potency topical steroid for atopic dermatitis, formulated with 0.05 percent desonide in Connetics' VersaFoam-EF vehicle, ... BioWorld Online - BioWorld Online Merger and Acquisition Scenario - Sep 6, 2008 Desonate (Desonide); Dowpharma Contract Manufacturing Services; The Dow Chemical Company Chemicals/Performance Chemicals; The Dow Chemical Company ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 15, 2007 Target. Desonate (Desonide); Dowpharma Contract Manufacturing Services ... Desonate (Desonide). Outsourced Services. Development/Manufacturing Services ... $250.00 - Revere Reports - Revere Severity assessment bolsters dermatitis treatment.(Pediatric Dermatolo... - Apr 1, 2008 Three products have received Food and Drug Administration approval for use in patients as young as 3 months of age: desonide nonethanolic foam (Verdeso, ... Pay-Per-View - Skin & Allergy News - HighBeam Research Merger and Acquisition Scenario - Sep 15, 2007 Target. Desonate (Desonide); Dowpharma Contract Manufacturing Services ... Desonate (Desonide). Outsourced Services. Development/Manufacturing Services ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Feb 23, 2008 Desonate (Desonide); Dowpharma Contract Manufacturing Services ... Desonate (Desonide). Outsourced Services. Development/Manufacturing Services ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 15, 2007 Target. Desonate (Desonide); Dowpharma Contract Manufacturing Services ... Desonate (Desonide). Outsourced Services. Development/Manufacturing Services ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 15, 2007 Target. Desonate (Desonide); Dowpharma Contract Manufacturing Services ... Desonate (Desonide). Outsourced Services. Development/Manufacturing Services ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jan 20, 2007 Target. Desonate (Desonide); Dowpharma Contract Manufacturing Services ... Desonate (Desonide). Outsourced Services. Development/Manufacturing Services ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 15, 2007 Target. Desonate (Desonide); Dowpharma Contract Manufacturing Services ... Desonate (Desonide). Outsourced Services. Development/Manufacturing Services ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 15, 2007 Desonate (Desonide); Dowpharma Contract Manufacturing Services ... Desonate (Desonide). Outsourced Services. Development/Manufacturing Services ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jan 13, 2007 Target. Desonate (Desonide); Dowpharma Contract Manufacturing Services ... Desonate (Desonide). Outsourced Services. Development/Manufacturing Services ... $250.00 - Revere Reports - Revere Article: Tips offered for managing atopic dermatitis.(Across Specialti... - Apr 1, 2008 Three products have received Food and Drug Administration approval for use in patients as young as 3 months of age: desonide nonethanolic foam (Verdeso, ... Pay-Per-View - Clinical Psychiatry News - HighBeam Research Merger and Acquisition Scenario - Sep 15, 2007 Target. Desonate (Desonide); Dowpharma Contract Manufacturing Services ... Desonate (Desonide). Nutritional Health. Dietary/Naturopathic Supplements ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 15, 2007 Target. Desonate (Desonide); Dowpharma Contract Manufacturing Services ... Desonate (Desonide). Outsourced Services. Development/Manufacturing Services ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 15, 2007 Desonate (Desonide); Dowpharma Contract Manufacturing Services ... Desonate (Desonide). Outsourced Services. Development/Manufacturing Services ... $250.00 - Revere Reports - Revere Low-potency steroid gel approved.(Products)(Brief article) | Article... - Feb 1, 2007 Desonate (desonide) gel 0.05% has been approved by the Food and Drug Administration for the treatment of mild... Pay-Per-View - Skin & Allergy News - HighBeam Research Merger and Acquisition Scenario - Sep 15, 2007 Desonate (Desonide); Dowpharma Contract Manufacturing Services ... Desonate (Desonide). Outsourced Services. Development/Manufacturing Services ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 15, 2007 Desonate (Desonide); Dowpharma Contract Manufacturing Services ... Desonate (Desonide). Outsourced Services. Development/Manufacturing Services ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 15, 2007 Target. Desonate (Desonide); Dowpharma Contract Manufacturing Services ... Desonate (Desonide). Nutritional Health. Dietary/Naturopathic Supplements ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - May 26, 2007 Desonate (Desonide); Dowpharma Contract Manufacturing Services ... Desonate (Desonide). Outsourced Services. Development/Manufacturing Services ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jun 2, 2007 Desonate (Desonide); Dowpharma Contract Manufacturing Services ... Desonate (Desonide). Outsourced Services. Development/Manufacturing Services ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Mar 17, 2007 Desonate (Desonide); Dowpharma Contract Manufacturing Services ... Desonate (Desonide). Nutritional Health. Dietary/Naturopathic Supplements ... $250.00 - Revere Reports - Revere Vehicles often drive treatment of difficult ailments.(Clinical... - Oct 1, 2006 The first, Desilux (desonide foam, Connetics), should be available by year's ... He predicts that SkinMedica also will introduce a desonide hydrogel later ... $4.95 - Dermatology Times - ECNext Topicals add new twists for pediatric dermatoses treatment.(Special … - Apr 1, 2007 Verdeso (desonide 0.05 percent foam; formerly Desilux, Connetics), a low-potency topical steroid recently approved for ages 3 months and older, ... $4.95 - Dermatology Times - ECNext Merger and Acquisition Scenario - Sep 15, 2007 Desonate (Desonide); Dowpharma Contract Manufacturing Services ... Desonate (Desonide). Outsourced Services. Development/Manufacturing Services ... $250.00 - Revere Reports - Revere Asymmetric dermal mucinosis.(Case of the Month)(Clinical report) |... - May 1, 2007 Article: Desonide foam improves atopic pruritus.(PEDIATRIC ... ... Desonide is a low-potency corticosteroid approved in ... medicine (dermatology) at the ... Pay-Per-View - Skin & Allergy News - HighBeam Research Steroids for hemangiomas don't jeopardize height.(Pediatric Dermatolog... - Sep 1, 2007 Article: Desonide foam improves atopic pruritus.(PEDIATRIC ... ... Desonide is a low-potency corticosteroid approved in the United States for the treatment ... Pay-Per-View - Skin & Allergy News - HighBeam Research Bleach baths for reducing S. aureus in atopy underused.(Pediatric … - Sep 1, 2007 Article: Desonide foam improves atopic pruritus.(PEDIATRIC ... ... Desonide is a low-potency corticosteroid approved in the United States for the treatment ... Pay-Per-View - Skin & Allergy News - HighBeam Research President leaves PediaMed after sales force sold - Feb 27, 2006 Desilux (desonide) VersaFoam-EF, 0.05%, a low-potency topical steroid formulated to treat atopic dermatitis, is Connetics' first drug candidate seeking a ... Bizjournals.com ë°”ë¥¸ì–¸ë¡ ë¹ ë¥¸ë‰´ìŠ¤ ì?¸í„°ë„· 연합뉴스 - May 7, 2008 Soriatane(R) CK CONVENIENCE KITì—? ì?´ìš©í• 수 있는 Soriatane(R) (acitretin) 캡ìŠ? ; Verdeso(R) (desonide) Foam, 0.05%; Brevoxyl(R)-4 í?¬ë¦¬ë¯¸ 워쉬(benzoyl ... 연합뉴스 Biotech at the beauty counter - Jun 1, 2007 ...surrounding skin; Vaniqua, which eliminates unwanted facial hair; EpiQuin Micro for acne; and Desonate (desonide), a gel for treating atopic dermatitis. ... Nature.com Connetics Files Patent Infringement Lawsuit Against Agis, a Wholly- … - Oct 20, 2005 Connetics is developing Velac(R) (a combination of 1% clindamycin and 0.025% tretinoin) Gel, for treating acne, Desilux(TM) (desonide) VersaFoam-EF, 0.05%, ... RedOrbit Connetics Names Luis Pena Vice President, Project Management; … - Aug 22, 2005 Connetics is developing Velac(R) (a combination of 1% clindamycin and 0.025% tretinoin) Gel, for treating acne, Desilux(TM) (desonide) VersaFoam-EF, 0.05%, ... RedOrbit Stiefel Laboratories, Inc. Kuasai ABR Invent dan ABR Development - May 7, 2008 0.05 persen dan Olux-E(TM) KEMASAN LENGKAP; Soriatane(R) (acitretin) Kapsul tersedia di Soriatane(R) CK CONVENIENCE KIT; Verdeso(R) (desonide) Busa, ... ANTARA Stiefel Laboratories Angkat Kepala Ilmiah Utama - Apr 8, 2008 0.05 persen dan Olux-E(TM) KEMASAN LENGKAP; Soriatane(R) (acitretin) Kapsul tersedia di Soriatane(R) CK CONVENIENCE KIT; Verdeso(TM) (desonide) Busa, ... ANTARA Stiefel Laboratories Will Enter Into Private Equity Minority Investmen... - Aug 9, 2007 Olux-E(TM) (clobetasol propionate) Foam, 0.05%; Soriatane(R) (acitretin) capsules; Verdeso(TM) (desonide) Foam, 0.05%; Brevoxyl(R) Creamy Wash (benzoyl ... Free with registration - PR Newswire - AccessMyLibrary.com Go-Ahead Given to Four Drugs for Cardio Conditions, Eczema, MS, and … - Oct 23, 2006 SkinMedica's Desonate (desonide gel) 0.05% received the go ahead for the treatment of mild-to-moderate atopic dermatitis. It is a low-potency topical ... Genetic Engineering News - Genetic Engineering News (press release) Connetics Reports Second Quarter Financial Results. - Aug 14, 2006 Connetics is developing Desilux(TM) (desonide) VersaFoam-EF, 0.05%, a low-potency topical steroid formulated to treat atopic dermatitis; Primolux(TM) ... $4.95 - Business Wire - ECNext Connetics Announces 2005 Analyst and Investor Day in New York City; … - Mar 10, 2005 Connetics is developing Velac(R) (a combination of 1% clindamycin and 0.025% tretinoin) Gel, for treating acne, and Desilux(TM) (desonide) VersaFoam-EF, ... Free with registration - Business Wire - AccessMyLibrary.com Connetics Announces Expiration of Hart-Scott-Rodino Waiting Period. - Dec 15, 2006 ...q([R]) (betamethasone valerate) Foam, 0.12%; Soriatane([R]) (acitretin) capsules; Evoclin([R]) (clindamycin) Foam, 1%; and Verdeso[TM] (desonide) Foam, ... Free with registration - Business Wire - AccessMyLibrary.com DermTech and Stiefel Laboratories, Inc. Begin Feasibility Study to … - Jan 7, 2008 0.05%) Foam; Olux-E(TM) (clobetasol propionate, 0.05%) Foam; Soriatane(R) (acitretin) CK CONVENIENCE KIT(TM); Verdeso(TM) (desonide, 0.05%) Foam; ... Free with registration - PR Newswire - AccessMyLibrary.com Connetics Receives Notice from Nasdaq Due to Late Filing of Form 10... - May 19, 2006 Connetics is developing Desilux(TM) (desonide) VersaFoam-EF, 0.05%, a low-potency topical steroid formulated to treat atopic dermatitis; Primolux(TM) ... Free with registration - Business Wire - AccessMyLibrary.com Connetics Licenses Technology for the Treatment of Hyperhidrosis. - Mar 7, 2006 Connetics is developing Desilux(TM) (desonide) VersaFoam-EF, 0.05%, a low-potency topical steroid formulated to treat atopic dermatitis; Primolux(TM) ... Free with registration - Business Wire - AccessMyLibrary.com Stiefel Laboratories Receives FDA Approval of Olux-E (Clobetasol … - Jan 23, 2007 Products formulated with VersaFoam-EF are Olux-E® (clobetasol propionate) Foam, 0.05%, and Verdesoâ„¢ (desonide) Foam, 0.05%. Products delivered via VersaFoam ... DG News DUSA Expands Global Sales With Launch of Levulan ® Kerastick ® in … - Oct 1, 2007 Olux TM (clobetasol propionate) Foam, 0.05%; Olux-E TM (clobetasol propionate) Foam, 0.05%; Soriatane ® (acitretin) capsules; Verdeso TM (desonide) Foam ... marketwire.com New Rogaine(R) Foam Features Connetics' Proprietary VersaFoam(R) … - Sep 5, 2006 Connetics is developing Desilux(TM) (desonide) Foam, 0.05%, a low-potency topical steroid formulated to treat atopic dermatitis; Primolux(TM) (clobetasol ... Free with registration - Business Wire - AccessMyLibrary.com Connetics Names Shari Geffon Senior Director, Project Management; … - Jun 5, 2006 Connetics is developing Desilux(TM) (desonide) VersaFoam-EF, 0.05%, a low-potency topical steroid formulated to treat atopic dermatitis; Primolux(TM) ... Free with registration - Business Wire - AccessMyLibrary.com Connetics Names Tim Pergram Regional Sales Director; Reports New … - May 30, 2006 Connetics is developing Desilux(TM) (desonide) VersaFoam-EF, 0.05%, a low-potency topical steroid formulated to treat atopic dermatitis; Primolux(TM) ... Free with registration - Business Wire - AccessMyLibrary.com Brand Names/Synonyms: Desonide is also known by the following brand names and/or synonymsBidien; Budeson; Budesonide; Budesonide, Pharma; BudesonideÊ; Cortivent; Desonide; Desowen; Entocort; Entocort Ec; Micronyl; Preferid; Pulmicort; Pulmicort Nebuamp; Pulmicort Respules; Pulmicort Turbuhaler; Rhinocort; Rhinocort Aqua; Rhinocort Turbuhaler; Spirocort; Tridesilon Drug Category: Desonide is categorized under the following by the FDA: Bronchodilator Agents; Anti-inflammatory Agents; Corticosteroids; ATC:A07EA06; ATC:D07AC09; ATC:R01AD05; ATC:R03BA02 Dosage Forms: CAPSULE (SUSTAINED-RELEASE); METERED-DOSE (AEROSOL); SUSPENSION Absorption: Complete Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: Not Available |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
